Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 3, 2015, Pages 453-462

  Kemp, William ^a   Levy, Miriam ^d   Weltman, Martin ^e   Lubel, John ^b,c  

^a ALFRED HOSPITAL   (Australia)

^b EASTERN HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d LIVERPOOL HOSPITAL   (Australia)

^e NEPEAN HOSPITAL   (Australia)

Author keywords

Clinical; Hepatitis B; Hepatitis C; Hepatology; Liver fibrogenesis; Public policy; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ALGORITHM; ANTIVIRAL THERAPY; ARTERY BLOOD FLOW; CHILD PUGH SCORE; CONSENSUS; DIAGNOSTIC ACCURACY; DIET RESTRICTION; ELASTOGRAPH; ELASTOGRAPHY; FATTY LIVER; FOOD INTAKE; HEPATITIS B; HEPATITIS C; HEPATOBILIARY PARAMETERS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER STIFFNESS MEASUREMENT; MEASUREMENT ERROR; MEDICAL SOCIETY; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OVERALL SURVIVAL; PARAMEDICAL EDUCATION; PORTAL HYPERTENSION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SUPINE POSITION; TRANSIENT ELASTOGRAPHY; VENOUS PRESSURE; WORK EXPERIENCE; AUSTRALIA; COMPLICATION; CONSENSUS DEVELOPMENT; EXPERT WITNESS; GASTROENTEROLOGY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; ORGANIZATION AND MANAGEMENT; PROCEDURES;

AUSTRALIA; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; ELASTICITY IMAGING TECHNIQUES; EXPERT TESTIMONY; GASTROENTEROLOGY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; LIVER CIRRHOSIS; SOCIETIES, MEDICAL;

EID: 84923225789     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12865     Document Type: Review

References (87)

1. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J. Hepatol. 2008; 48: 835-847.
2. de Ledinghen V, Vergniol J. Transient elastography for the diagnosis of liver fibrosis. Expert Rev. Med. Devices 2010; 7: 811-823.
3. Sandrin L, Fourquet B, Hasquenoph JM etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 2003; 29: 1705-1713.
4. Castera L, Foucher J, Bernard PH etal. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13, 369 examinations. Hepatology 2010; 51: 828-835.
5. Kettaneh A, Marcellin P, Douvin C etal. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J. Hepatol. 2007; 46: 628-634.
6. Kemp W, Roberts S. Feasibility and performance of the FibroScan XL probe. Hepatology 2012; 55: 1308-1309; author reply 9-10.
7. Robic MA, Procopet B, Metivier S etal. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J. Hepatol. 2011; 55: 1017-1024.
8. de Ledinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010; 30: 1043-1048.
9. Myers RP, Pomier-Layrargues G, Kirsch R etal. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012; 55: 199-208.
10. Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int. 2010; 30: 1471-1480.
11. Lucidarme D, Foucher J, Le Bail B etal. Factors of accuracy of transient elastography (FibroScan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1083-1089.
12. Boursier J, Zarski JP, de Ledinghen V etal. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 2013; 57: 1182-1191.
13. Boursier J, Konate A, Guilluy M etal. Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography. Eur. J. Gastroenterol. Hepatol. 2008; 20: 693-701.
14. Fraquelli M, Rigamonti C, Casazza G etal. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-973.
15. Degos F, Perez P, Roche B etal. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J. Hepatol. 2010; 53: 1013-1021.
16. Arena U, Lupsor Platon M, Stasi C etal. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology 2013; 58: 65-72.
17. Berzigotti A, De Gottardi A, Vukotic R etal. Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension. PLoS ONE 2013; 8: e58742.
18. Mederacke I, Wursthorn K, Kirschner J etal. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int. 2009; 29: 1500-1506.
19. Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J. Hepatol. 2009; 50: 1-3.
20. Friedrich-Rust M, Ong MF, Martens S etal. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-974.
21. Bedossa P. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy. Liver Int. 2009; 29 (Suppl. 1): 19-22.
22. Westin J, Lagging LM, Wejstal R, Norkrans G, Dhillon AP. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver. 1999; 19: 183-187.
23. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457.
24. Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J. Hepatol. 2009; 50: 36-41.
25. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006; 55: 569-578.
26. Vergniol J, Foucher J, Terrebonne E etal. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-1979, 9 e1-3.
27. Vizzutti F, Arena U, Romanelli RG etal. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297.
28. Masuzaki R, Tateishi R, Yoshida H etal. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009; 49: 1954-1961.
29. Jung KS, Kim SU, Ahn SH etal. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011; 53: 885-894.
30. Verveer C, Zondervan PE, ten Kate FJ, Hansen BE, Janssen HL, de Knegt RJ. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int. 2012; 32: 622-628.
31. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J. Hepatol. 2011; 54: 650-659.
32. Arena U, Vizzutti F, Corti G etal. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47: 380-384.
33. Millonig G, Reimann FM, Friedrich S etal. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008; 48: 1718-1723.
34. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832.
35. Everhart JE, Wright EC, Goodman ZD etal. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 2010; 51: 585-594.
36. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J. Hepatol. 2011; 55: 245-264.
37. Arena U, Vizzutti F, Abraldes JG etal. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008; 57: 1288-1293.
38. Cardoso AC, Carvalho-Filho RJ, Stern C etal. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 2012; 32: 612-621.
39. Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J. Viral Hepat. 2009; 16: 300-314.
40. Castera L, Vergniol J, Foucher J etal. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350.
41. Cross TJ, Calvaruso V, Maimone S etal. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. J. Viral Hepat. 2010; 17: 546-554.
42. Lupsor M, Badea R, Stefanescu H etal. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients. J. Gastrointestin. Liver Dis. 2008; 17: 155-163.
43. Lupsor Platon M, Stefanescu H, Feier D, Maniu A, Badea R. Performance of unidimensional transient elastography in staging chronic hepatitis C. Results from a cohort of 1, 202 biopsied patients from one single center. J. Gastrointestin. Liver Dis. 2013; 22: 157-166.
44. Sporea I, Sirli R, Deleanu A etal. Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World J. Gastroenterol. 2010; 16: 4832-4837.
45. Zarski JP, Sturm N, Guechot J etal. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J. Hepatol. 2012; 56: 55-62.
46. Ziol M, Handra-Luca A, Kettaneh A etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
47. Castera L, Le Bail B, Roudot-Thoraval F etal. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J. Hepatol. 2009; 50: 59-68.
48. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012; 142: 1293-1302, e4.
49. Calvaruso V, Camma C, Di Marco V etal. Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy. J. Viral Hepat. 2010; 17: 469-474.
50. Wang HM, Hung CH, Lu SN etal. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver Int. 2013; 33: 756-761.
51. Foucher J, Chanteloup E, Vergniol J etal. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-408.
52. Bureau C, Metivier S, Peron JM etal. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment. Pharmacol. Ther. 2008; 27: 1261-1268.
53. Lemoine M, Katsahian S, Ziol M etal. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment. Pharmacol. Ther. 2008; 28: 1102-1110.
54. Colecchia A, Montrone L, Scaioli E etal. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology 2012; 143: 646-654.
55. Vergniol J, Boursier J, Coutzac C etal. The evolution of non-invasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology 2014; 60: 65-76.
56. Castera L, Sebastiani G, Le Bail B, de Ledinghen V, Couzigou P, Alberti A. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J. Hepatol. 2010; 52: 191-198.
57. Boursier J, Vergniol J, Sawadogo A etal. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int. 2009; 29: 1507-1515.
58. Poynard T, Vergniol J, Ngo Y etal. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest) and transient elastography (FibroScan[R]). J. Hepatol. 2014; 60: 706-714.
59. Fraquelli M, Rigamonti C, Casazza G etal. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J. Hepatol. 2011; 54: 621-628.
60. Scott DR, Levy MT. Liver transient elastography (Fibroscan): a place in the management algorithms of chronic viral hepatitis. Antivir. Ther. 2010; 15: 1-11.
61. Tapper EB, Cohen EB, Patel K etal. Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin. Gastroenterol. Hepatol. 2012; 10: 932-937.
62. Boursier J, de Ledinghen V, Sturm N etal. Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C. J. Gastroenterol. 2014; 49: 527-537.
63. Sanchez-Conde M, Montes Ramirez ML, Bellon Cano JM etal. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus. J. Viral Hepat. 2011; 18: e278-283.
64. Sanchez-Conde M, Miralles P, Bellon JM etal. Use of transient elastography (FibroScan[R]) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients. J. Viral Hepat. 2011; 18: 685-691.
65. Colletta C, Smirne C, Fabris C etal. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42: 838-845.
66. GESA. Clinical update: chronic hepatitis B (CHB) recommendations. 2010.
67. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662.
68. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J. Hepatol. 2012; 57: 167-185.
69. Sarri G, Westby M, Bermingham S, Hill-Cawthorne G, Thomas H. Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance. BMJ 2013; 346: f3893.
70. Marcellin P, Ziol M, Bedossa P etal. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009; 29: 242-247.
71. Vigano M, Paggi S, Lampertico P etal. Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation. Aliment. Pharmacol. Ther. 2011; 34: 353-362.
72. Oliveri F, Coco B, Ciccorossi P etal. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J. Gastroenterol. 2008; 14: 6154-6162.
73. Lesmana CR, Salim S, Hasan I etal. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting. J. Clin. Pathol. 2011; 64: 916-920.
74. Chan HL, Wong GL, Choi PC etal. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (FibroScan) for liver fibrosis in chronic hepatitis B. J. Viral Hepat. 2009; 16: 36-44.
75. Kim do Y, Kim SU, Ahn SH etal. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig. Dis. Sci. 2009; 54: 1758-1763.
76. Vigano M, Massironi S, Lampertico P etal. Changes in liver stiffness during entecavir therapy in patients with chronic hepatitis B. Hepatology 2009; 50: S145.
77. Andersen ES, Weiland O, Leutscher P etal. Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs. Scand. J. Gastroenterol. 2011; 46: 760-766.
78. Kim BK, Fung J, Yuen MF, Kim SU. Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J. Gastroenterol. 2013; 19: 1890-1900.
79. Wong GL, Wong VW, Choi PC etal. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antiviral Ther. 2011; 16: 165-172.
80. Lim SG, Cho SW, Lee YC etal. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B. Hepatogastroenterology 2011; 58: 539-545.
81. Fung J, Lai CL, Wong DK, Seto WK, Hung I, Yuen MF. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study. J. Viral Hepat. 2011; 18: e200-205.
82. Papatheodoridis GV, Manolakopoulos S, Margariti A etal. The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection. J. Viral Hepat. 2014; 21: 517-524.
83. Poynard T, Vergniol J, Ngo Y etal. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest[R]) and elastography (FibroScan[R]). J. Hepatol. 2014; 60: 706-714.
84. Assal A, Mackie D, Cooper CL. Transient elastography, APRI, and ultrasound have minimal utility in chronic low-replicative hepatitis B infection. Eur. J. Gastroenterol. Hepatol. 2014; 26: 1010-1014.
85. Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination. J. Gastroenterol. Hepatol. 2013; 28: 1842-1848.
86. Castera L, Bernard PH, Le Bail B etal. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment. Pharmacol. Ther. 2011; 33: 455-465.
87. Castera L. Hepatitis B: are non-invasive markers of liver fibrosis reliable? Liver Int. 2014; 34 (Suppl. 1): 91-96.